When diagnosed with thrombocytopenia (low platelet count), many patients worry: “Does this mean I can’t live normally?” The answer is: you can, but your lifestyle will require s...

Natural killer (NK) cells play a central role within the innate immune system and are able to recognize abnormal cells without prior sensitization. In recent years, NK cell–based ...

When undergoing targeted cancer therapy, diet often becomes a concern for many patients. The truth is, there’s no need for overly strict restrictions, but maintaining a light, bal...

The U.S. Food and Drug Administration has granted approval to Otsuka’s newly developed injectable therapy for patients diagnosed with primary immunoglobulin A nephropathy (IgAN), ...

Why Cancer Patients Should Eat Less Sugar: The Hidden Link Between Sugar and Tumor GrowthMany cancer patients are told by doctors to “avoid sugar.” But why?Sugar is not poison—b...

Treatment of type 1 diabetes (T1D) is entering a transformative era. The first immunotherapy approved to delay clinical onset—Teplizumab—has received FDA approval in the United S...

Cancer patients undergoing treatment require a carefully managed diet and healthy lifestyle to support recovery, improve treatment tolerance, and enhance quality of life. Here is a...

Can You Drink Alcohol While Taking Targeted Therapy Drugs? Doctors Explain Why It’s Not RecommendedOne of the most common questions from cancer patients is:'Can I drink a little a...

September 30, 2025 — Gilead’s Epclusa (sofosbuvir/velpatasvir, 400mg/100mg) continues to reshape hepatitis C management worldwide. As the first and only all-oral, pan-genotypi...

With the rapid development of precision medicine, targeted drugs have become a key approach in cancer treatment. Unlike traditional chemotherapy, targeted therapy “hits” specific...